160 related articles for article (PubMed ID: 37880912)
1. Health care utilization by long-term survivors of blood or marrow transplantation-A Bone Marrow Transplant Survivor Study report.
Oliver MM; Meng Q; Hageman L; Landier W; Balas N; Ross E; Francisco L; Bosworth A; Te HS; Wong FL; Bhatia R; Forman SJ; Armenian SH; Weisdorf DJ; Bhatia S
Cancer; 2024 Mar; 130(5):803-815. PubMed ID: 37880912
[TBL] [Abstract][Full Text] [Related]
2. Late-occurring venous thromboembolism in allogeneic blood or marrow transplant survivors: a BMTSS-HiGHS2 risk model.
Gangaraju R; Chen Y; Hageman L; Wu J; Francisco L; Kung M; Weisdorf DJ; Forman SJ; Arora M; Armenian SH; Bhatia S
Blood Adv; 2021 Oct; 5(20):4102-4111. PubMed ID: 34461633
[TBL] [Abstract][Full Text] [Related]
3. Risk of COVID-19 infection in long-term survivors of blood or marrow transplantation: a BMTSS report.
Johnston EE; Meng Q; Hageman L; Wu J; Ross E; Lim S; Balas N; Bosworth A; Te HS; Francisco L; Bhatia R; Forman SJ; Wong FL; Armenian SH; Weisdorf DJ; Landier W; Bhatia S
Blood Adv; 2023 Jun; 7(12):2843-2854. PubMed ID: 36724527
[TBL] [Abstract][Full Text] [Related]
4. Burden of Morbidity after Allogeneic Blood or Marrow Transplantation for Inborn Errors of Metabolism: A BMT Survivor Study Report.
Wadhwa A; Chen Y; Hageman L; Schlichting E; Funk E; Hicks J; Balas N; Siler A; Wu J; Francisco L; Holmqvist A; Gupta A; Lund T; Orchard PJ; Armenian S; Arora M; Bhatia S
Transplant Cell Ther; 2022 Mar; 28(3):157.e1-157.e9. PubMed ID: 34879288
[TBL] [Abstract][Full Text] [Related]
5. Pain in older survivors of hematologic malignancies after blood or marrow transplantation: A BMTSS report.
Farrukh N; Hageman L; Chen Y; Wu J; Ness E; Kung M; Francisco L; Parman M; Landier W; Arora M; Armenian S; Bhatia S; Williams GR
Cancer; 2020 Jan; 126(9):2003-2012. PubMed ID: 32022263
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal trajectory of frailty in blood or marrow transplant survivors: Report from the Blood or Marrow Transplant Survivor Study.
Arora M; Chen Y; Wu J; Hageman L; Ness E; Kung M; Francisco L; Bosworth A; Weisdorf DJ; Forman SJ; Landier W; Pamukçuoğlu M; Armenian SH; Wong FL; Bhatia S
Cancer; 2021 Mar; 127(5):794-800. PubMed ID: 33206383
[TBL] [Abstract][Full Text] [Related]
7. Potentially inappropriate medications in geriatric blood or marrow transplantation (BMT) survivors: A BMT Survivor Study report.
Sanchez-Luege S; Landier W; Dai C; Hageman L; Ross ES; Balas NA; Bosworth A; Te HS; Wu J; Francisco L; Wong FL; Forman SJ; Armenian SH; Weisdorf DJ; Bhatia S
Cancer; 2023 Feb; 129(3):473-482. PubMed ID: 36413424
[TBL] [Abstract][Full Text] [Related]
8. Total Body Irradiation and Risk of Breast Cancer After Blood or Marrow Transplantation: A Blood or Marrow Transplantation Survivor Study Report.
McDonald AM; Chen Y; Wu J; Hageman L; Francisco L; Kung M; Wong FL; Ness E; Landier W; Battles K; Salzman D; Weisdorf DJ; Forman SJ; Arora M; Armenian SH; Bhatia S
J Clin Oncol; 2020 Sep; 38(25):2872-2882. PubMed ID: 32673169
[TBL] [Abstract][Full Text] [Related]
9. Health care utilization by adult Hispanic long-term survivors of hematopoietic stem cell transplantation: report from the Bone Marrow Transplant Survivor Study.
Prasad PK; Sun CL; Baker KS; Francisco L; Forman S; Bhatia S; Shankar SM
Cancer; 2008 Nov; 113(10):2724-33. PubMed ID: 18831512
[TBL] [Abstract][Full Text] [Related]
10. Neighborhood disadvantage, health status, and health care utilization after blood or marrow transplant: BMTSS report.
Wolfson JA; Bhatia S; Hageman L; Ross ES; Balas N; Bosworth A; Te HS; Francisco L; Funk E; Hicks J; Landier W; Wu J; Siler A; Lim S; Wong FL; Armenian SH; Arora M; Aswani MS
Blood Adv; 2023 Feb; 7(3):293-301. PubMed ID: 35834730
[TBL] [Abstract][Full Text] [Related]
11. Severe, life-threatening, and fatal chronic health conditions after allogeneic blood or marrow transplantation in childhood.
Holmqvist AS; Chen Y; Hageman L; Landier W; Wu J; Francisco LF; Ross ES; Balas NA; Bosworth A; Te HS; Goldman FD; Rosenthal J; Wong FL; Weisdorf DJ; Armenian SH; Bhatia S
Cancer; 2023 Feb; 129(4):624-633. PubMed ID: 36484292
[TBL] [Abstract][Full Text] [Related]
12. What They Want: Inclusion of Blood and Marrow Transplantation Survivor Preference in the Development of Models of Care for Long-Term Health in Sydney, Australia.
Dyer G; Gilroy N; Brown L; Hogg M; Brice L; Kabir M; Greenwood M; Larsen SR; Moore J; Hertzberg M; Kwan J; Huang G; Tan J; Ward C; Kerridge I
Biol Blood Marrow Transplant; 2016 Apr; 22(4):731-743. PubMed ID: 26746819
[TBL] [Abstract][Full Text] [Related]
13. Trends in Late Mortality and Life Expectancy After Allogeneic Blood or Marrow Transplantation Over 4 Decades: A Blood or Marrow Transplant Survivor Study Report.
Bhatia S; Dai C; Landier W; Hageman L; Wu J; Schlichting E; Siler A; Funk E; Hicks J; Bosworth A; Te HS; Francisco L; Bhatia R; Salzman D; Goldman FD; Forman SJ; Weisdorf DJ; Wong FL; Arora M; Armenian SH
JAMA Oncol; 2021 Nov; 7(11):1626-1634. PubMed ID: 34499078
[TBL] [Abstract][Full Text] [Related]
14. Burden of Long-Term Morbidity Borne by Survivors of Acute Myeloid Leukemia Treated With Blood or Marrow Transplantation: The Results of the BMT Survivor Study.
Armenian SH; Chen Y; Hageman L; Wu J; Landier W; Bosworth A; Francisco L; Schlichting E; Bhatia R; Salzman D; Wong FL; Weisdorf DJ; Forman SJ; Arora M; Bhatia S
J Clin Oncol; 2022 Oct; 40(28):3278-3288. PubMed ID: 35731989
[TBL] [Abstract][Full Text] [Related]
15. Long-term treatment burden following allogeneic blood and marrow transplantation in NSW, Australia: a cross-sectional survey.
McErlean G; Brice L; Gilroy N; Kabir M; Greenwood M; Larsen SR; Moore J; Gottlieb D; Hertzberg M; Brown L; Hogg M; Huang G; Ward C; Kerridge I
J Cancer Surviv; 2022 Apr; 16(2):432-444. PubMed ID: 33813667
[TBL] [Abstract][Full Text] [Related]
16. Late Mortality after Allogeneic Blood or Marrow Transplantation for Inborn Errors of Metabolism: A Report from the Blood or Marrow Transplant Survivor Study-2 (BMTSS-2).
Wadhwa A; Chen Y; Holmqvist A; Wu J; Ness E; Parman M; Kung M; Hageman L; Francisco L; Braunlin E; Miller W; Lund T; Armenian S; Arora M; Orchard P; Bhatia S
Biol Blood Marrow Transplant; 2019 Feb; 25(2):328-334. PubMed ID: 30292746
[TBL] [Abstract][Full Text] [Related]
17. Late mortality after bone marrow transplant for chronic myelogenous leukemia in the context of prior tyrosine kinase inhibitor exposure: A Blood or Marrow Transplant Survivor Study (BMTSS) report.
Wu J; Chen Y; Hageman L; Francisco L; Ness EC; Parman M; Kung M; Watson JA; Weisdorf DJ; Snyder DS; McGlave PB; Forman SJ; Arora M; Armenian SH; Bhatia R; Bhatia S
Cancer; 2019 Nov; 125(22):4033-4042. PubMed ID: 31412155
[TBL] [Abstract][Full Text] [Related]
18. Morbidity burden in survivors of multiple myeloma who underwent autologous transplantation: A Bone Marrow Transplantation Survivor Study.
Arora M; Chen Y; Hageman L; Wu J; Landier W; Francisco L; Kung M; Ness E; Bosworth A; Pamukcuoglu M; Weisdorf DJ; Forman SJ; Armenian SH; Bhatia S
Cancer; 2020 Jul; 126(14):3322-3329. PubMed ID: 32413187
[TBL] [Abstract][Full Text] [Related]
19. Late morbidity and mortality after autologous blood or marrow transplantation for lymphoma in children, adolescents and young adults-a BMTSS report.
Holmqvist AS; Meng Q; Dai C; Hageman L; Landier W; Wu J; Francisco LF; Ross ES; Balas N; Bosworth A; Te HS; Bhatia R; Rosenthal J; Wong FL; Weisdorf D; Armenian SH; Bhatia S
Leukemia; 2024 Mar; 38(3):601-609. PubMed ID: 38374408
[TBL] [Abstract][Full Text] [Related]
20. Venous Thromboembolism in Autologous Blood or Marrow Transplantation Survivors: A Report from the Blood or Marrow Transplant Survivor Study.
Gangaraju R; Chen Y; Hageman L; Wu J; Francisco L; Battles K; Kung M; Ness E; Parman M; Weisdorf DJ; Forman SJ; Arora M; Armenian SH; Bhatia S
Biol Blood Marrow Transplant; 2019 Nov; 25(11):2261-2266. PubMed ID: 31278995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
